Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Graft vs. Host Disease – Competitive Landscape, Technology, Overview and Analysis 2016

Tuesday, October 25, 2016 11:29
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Publisher’s, “Graft vs. Host Disease- Competitive Landscape, Technology and Pipeline Analysis, 2016″, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under the category of Graft Versus Host Disease. Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. The complexity of immune-mediated disease occurs due to the interaction between the adaptive immunity of donor and recipient. It can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal (GI) tract, liver, oral mucosa, and eyes. It is the worldwide cause of mortality and morbidity. Several factors are responsible for Graft versus Host Disease such as blood transfusion, bone marrow transplant, stem cell transplant.

 

For more information about this report: http://www.reportsweb.com/graft-vs-host-disease-competitive-landscape-technology-and-pipeline-analysis-2016

This report provides information on the therapeutic development based on the Graft versus Host Disease dealing with around 57 active pipeline drugs. The report also covers the information for 53 active companies involved in the therapeutic development of the products.

Report Highlights:

- The new report, provides a Graft Versus Host Disease Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, development partner and chemical information

- Comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, Preclinical and Discovery stages

- Coverage of the Graft Versus Host Disease pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for Graft Versus Host Disease and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.

 

Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001337229/sample

 

Table of Contents

- Executive Summary 
- Overview
- Symptoms
- Pathophysiology
- Risk factors of GvHD
- Diagnosis
- Epidemiology
- Grading system of GVHD
- Treatment algorithm for GVHD
- Management of Graft versus Host Disease
- Recent Trends
- Pipeline Analysis
- Targets of Graft vs. Host Disease and Analysis
- Graft Versus Host Disease Collaborations and Deal Year
- Graft Versus Host Disease Collaborations and Deal value
- Companies’ Licensing Agreement for Graft Versus Host Disease
- Financing details of Graft Versus Host Disease
- Companies received Grants for Graft vs. Host Disease
- Designation Analysis
- Clinical trials analysis with completion year
- Graft Versus Host Disease Technologies
- Market Drivers
- Market Barriers
- SWOT Analysis
- Leading Companies
- Pipeline Therapeutics
- Therapeutics under Development by Companies
- Last Stage Products (Phase III)
- Comparative Analysis
- Mid Stage Products (Phase II)
- Comparative Analysis
- Early Stage Products (Phase I and IND)
- Comparative Analysis
- Pre-Clinical and Discovery Products
- Comparative Analysis
- Unknown Phase Products
- Therapeutic Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type

 

Inquire before Buying at http://www.reportsweb.com/inquiry&RW0001337229/buying

 

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.